Uldall P R, Kennedy I, Craske H, Porrett E, Aid J, Woods F, Levine D
Proc Clin Dial Transplant Forum. 1980;10:220-3.
A controlled, cross-over trial of bicarbonate versus acetate hemodialysis over a 24 wk period in 16 patients with end-stage renal failure has shown a significantly lower incidence of dialysis-related symptoms during dialysis with bicarbonate. The level of well-being in the intervals between dialysis was not appreciably affected by the dialysis mode. It is suggested that bicarbonate dialysis should be made available to all patients receiving regular hemodialysis for end-stage renal failure provided that this can be done reliably and safely.
一项针对16例终末期肾衰竭患者进行的为期24周的碳酸氢盐与醋酸盐血液透析对照交叉试验表明，使用碳酸氢盐进行血液透析时，透析相关症状的发生率显著降低。透析间隔期的健康状况并未受到透析模式的明显影响。建议只要能够可靠且安全地进行，应为所有接受终末期肾衰竭定期血液透析的患者提供碳酸氢盐透析。
